Company

Sagimet Biosciences Inc.

SGMT · CIK 0001400118

SEC FORM 4

$2,077,290.48

Acquisition (code M) of 326,618 shares at $6.36 per share.

Reporting Person Kemble George · Transaction Code M

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001193125-26-354018 · filed 2026-08-17 · View filing →

SEC FORM 4

$154,986.84

Acquisition (code M) of 24,369 shares at $6.36 per share.

Reporting Person Kemble George · Transaction Code M

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001193125-26-354018 · filed 2026-08-17 · View filing →

SEC FORM 4

$3,591,579.77

Sale of 350,987 shares at $10.2328 per share.

Reporting Person Kemble George · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001193125-26-354018 · filed 2026-08-17 · View filing →

SEC FORM 4

$62,016.36

Acquisition (code M) of 9,751 shares at $6.36 per share.

Reporting Person Kemble George · Transaction Code M

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-347407 · filed 2026-08-12 · View filing →

SEC FORM 4

$66,493.80

Acquisition (code M) of 10,455 shares at $6.36 per share.

Reporting Person Kemble George · Transaction Code M

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-347407 · filed 2026-08-12 · View filing →

SEC FORM 4

$201,146.69

Sale of 20,206 shares at $9.9548 per share.

Reporting Person Kemble George · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-347407 · filed 2026-08-12 · View filing →